CERS Cerus Corporation

NASDAQ
$2.49

Cerus Corporation (CERS) Insider Activity

What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.

Insider signal In line Selling ran in line with CERS's own trailing one-year pace, with 90% of sale value under a prearranged plan.
Cluster activity 0 buyers in the last 30 days 0 buyers in the last 90 days 4 sellers in the last 90 days
Insiders buying
0
0 transactions
Insiders selling
6
25 transactions
Purchases
$0
0 shares
Sales
$3.3M
1,677,913 shares
Net activity
-$3.3M
purchases less sales

How much of that selling was preplanned? 90% planned / 10% discretionary

10b5-1 plan sales $3.0M 21 transactions · 1,500,800 shares
Discretionary sales $349.0K 4 transactions · 177,113 shares

Largest single sale: $742.0K.

Where they traded

Buy Sell Dot area is proportional to transaction value.

Last open-market purchase: August 25, 2025 — 1.1 years ago, by Gregory Dean A. .

Recent open-market activity

Date Insider Role Action Shares Price Value Held after
Jensen Chrystal Chief Legal Officer Sell 10b5-1 30,000 $2.98 $89.5K 936,657 −3.1% of holding
Jayaraman Vivek K Chief Executive Officer Sell 10b5-1 16,666 $3.16 $52.7K 2,232,211 −0.7% of holding
Greenman William Mariner President and CEO Sell 10b5-1 101,919 $2.94 $299.9K 5,053,036 −2% of holding
Jayaraman Vivek K Chief Operating Officer Sell 10b5-1 42,359 $2.94 $124.7K 1,694,348 −2.4% of holding
Green Kevin Dennis Chief Financial Officer Sell 10b5-1 33,676 $2.94 $99.1K 1,062,188 −3.1% of holding
Jensen Chrystal Chief Legal Officer Sell 10b5-1 24,329 $2.94 $71.6K 966,657 −2.5% of holding
BJERKHOLT ERIC Director Sell 20,454 $2.60 $53.2K 261,679 −7.2% of holding
Jayaraman Vivek K Chief Operating Officer Sell 10b5-1 16,667 $3.00 $50.0K 1,656,707 −1% of holding
Jayaraman Vivek K Chief Operating Officer Sell 10b5-1 16,667 $3.00 $50.0K 1,673,374 −1% of holding
Greenman William Mariner President and CEO Sell 10b5-1 447,757 $1.66 $742.0K 4,998,493 −8.2% of holding
Jayaraman Vivek K Chief Operating Officer Sell 10b5-1 165,200 $1.66 $273.8K 1,747,674 −8.6% of holding
Green Kevin Dennis Chief Financial Officer Sell 10b5-1 127,544 $1.66 $211.4K 1,040,551 −10.9% of holding
Benjamin Richard J Chief Medical Officer Sell 10b5-1 101,740 $1.66 $168.6K 777,361 −11.6% of holding
Benjamin Richard J Chief Medical Officer Sell 40,426 $1.88 $76.0K 879,101 −4.4% of holding
Benjamin Richard J Chief Medical Officer Sell 10b5-1 40,426 $1.88 $76.0K 879,101 −4.4% of holding
Greenman William Mariner President and CEO Sell 10b5-1 78,187 $2.01 $156.8K 5,446,250 −1.4% of holding
Benjamin Richard J 2 fills Chief Medical Officer Sell 10b5-1 48,470 $2.01 $97.2K 919,527 −5% of holding
Jayaraman Vivek K Chief Operating Officer Sell 10b5-1 34,094 $2.01 $68.4K 1,912,874 −1.8% of holding
Jensen Chrystal Chief Legal Officer Sell 10b5-1 30,845 $2.01 $61.9K 1,059,139 −2.8% of holding
Green Kevin Dennis Chief Financial Officer Sell 10b5-1 27,796 $2.01 $55.7K 1,168,095 −2.3% of holding
Benjamin Richard J Chief Medical Officer Sell 61,233 $2.06 $126.3K 943,762 −6.1% of holding
Benjamin Richard J Chief Medical Officer Sell 10b5-1 61,233 $2.06 $126.3K 943,762 −6.1% of holding
Green Kevin Dennis Chief Financial Officer Sell 10b5-1 55,225 $2.06 $113.9K 1,195,891 −4.4% of holding
Jensen Chrystal Chief Legal Officer Sell 55,000 $1.70 $93.5K 728,294 −7% of holding

Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.